Navigation Links
PSEG Supports Quick Congressional Action on Clean Air in Wake of Court's Rescinding of CAIR
Date:7/29/2008

Power company says impact is 'significant and substantial' and calls for

multi-pollutant legislation

NEWARK, N.J., July 29 /PRNewswire-FirstCall/ -- Eric Svenson, PSEG's vice president of environment, health and safety, testified today before Congress about the implications of a recent federal appeals court decision that struck down the Environmental Protection Agency's Clean Air Interstate Rule (also known as CAIR). CAIR would have resulted in dramatic reductions in particulate matter and ozone and helped to eliminate smog, asthma and other chronic and acute respiratory effects. Clean air and public health are threatened in its absence.

Svenson told the Senate Clean Air and Nuclear Safety Subcommittee that the impact of the ruling would be "significant and substantial" and called for Congress to act quickly to pass multi-pollutant legislation like that championed by subcommittee chairman Senator Tom Carper (D-DE).

He said the rescinding of CAIR and the continued implementation of a patchwork of state and regional programs governing carbon dioxide have created "a chaotic regulatory environment."

PSEG believes that legislation addressing the four major power plant pollutants -- nitrogen (NOX), sulfur dioxide (SO2), carbon dioxide (CO2) and mercury -- is critical for ensuring timely public health and environmental benefits, business certainty, and a level playing field for the electric generating sector.

Svenson urged Congress to restart the legislative discussion and quickly pass multi-pollutant legislation, saying that the electric sector "needs certainty."

CAIR would have resulted in considerable public health benefits as well as increased industry investment in pollution controls. With the rescinding of CAIR, "we are stuck with an inefficient, more expensive system with significant public health costs and much less environmental benefit," Svenson told Congress.

"The ruling threatens to tie the hands of the EPA as it tries to find economically efficient and effective methods to improve public health and our environment," Svenson said. He added that the ruling leaves "a huge regulatory hole."

Go to the "news" section at http://www.pseg.com to see Svenson's written and oral testimony in its entirety.

Public Service Enterprise Group (PSEG) is a publicly traded diversified energy company with annual revenues of more than $13 billion, and three principal subsidiaries: PSEG Power, PSEG Energy Holdings, and Public Service Electric and Gas Company (PSE&G). PSEG Power, one of the largest independent power producers in the U.S. has three main subsidiaries: PSEG Fossil, PSEG Nuclear, and PSEG Energy Resources & Trade. PSEG Energy Holdings has two main unregulated energy-related businesses: PSEG Global and PSEG Resources. PSE&G, New Jersey's oldest and largest regulated gas and electric delivery utility, serves nearly three-quarters of New Jersey's population.


'/>"/>
SOURCE Public Service Enterprise Group (PSEG)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
2. Diageo Supports First Ever National We Dont Serve Teens Week
3. The Prem Rawat Foundation Supports Disaster-Relief Efforts in Mozambique
4. Discovery supports theory of Alzheimers disease as form of diabetes
5. Study Supports Change to Prostate Cancer Biopsy
6. Kim & Scotts Gourmet Pretzels(TM) Supports Breast Cancer Organizations With Its New Pink Ribbon Pretzel
7. NIH grant supports UCSF research exploring early HIV infection
8. Grant Supports Study of Abnormal Ring-Shaped Chromosomes
9. Adaptis Supports Local Yakima-Based YWCA and National Diabetes
10. XShares Supports Parkinsons Disease Foundation 50th Anniversary Educational Symposium
11. $4 million AHRQ grant supports research to improve hospital care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: